"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Amicar Patient Information including How Should I Take
In this Article
- What is aminocaproic acid (Amicar)?
- What are the possible side effects of aminocaproic acid (Amicar)?
- What is the most important information I should know about aminocaproic acid (Amicar)?
- What should I discuss with my health care provider before using aminocaproic acid (Amicar)?
- How should I use aminocaproic acid (Amicar)?
- What happens if I miss a dose (Amicar)?
- What happens if I overdose (Amicar)?
- What should I avoid while taking aminocaproic acid (Amicar)?
- What other drugs will affect aminocaproic acid (Amicar)?
- Where can I get more information?
What should I discuss with my health care provider before using aminocaproic acid (Amicar)?
You should not use this medication if you are allergic to it. Your doctor will perform blood tests to make sure you do not have other conditions that would prevent you from safely using aminocaproic acid.
To make sure you can safely take aminocaproic acid, tell your doctor if you have any of these other conditions:
- kidney disease; or
- a history of stroke or blood clots;
FDA pregnancy category C. It is not known whether aminocaproic acid will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
It is not known whether aminocaproic acid passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
Do not give this medication to a child.
How should I use aminocaproic acid (Amicar)?
Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Start using the medication at the first sign of a bleeding episode. Your first dose may be much higher than the doses you use later on. Follow your doctor's dosing instructions very carefully.
Treatment with aminocaproic acid is usually continued hourly for 8 hours or until the bleeding has stopped.
Aminocaproic acid is either taken by mouth or injected into a vein through an IV.
You may need to first use the injection form and then use an oral form (tablet or liquid). Follow your doctor's instructions.
A healthcare provider will give you this injection. You may be shown how to use an IV at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles, IV tubing, and other items used to inject the medicine.
Take the aminocaproic acid tablets with a full glass (8 ounces) of water.
Measure the oral syrup with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
The injectable form of aminocaproic acid must be mixed with a liquid (diluent) before using it. If you are using the injections at home, be sure you understand how to properly mix and store the medication.
Do not use the aminocaproic acid injection if it has changed colors or has particles in it. Call your doctor for a new prescription.
To be sure this medication is not causing harmful effects, your blood cells and kidney function may need to be tested often. Aminocaproic acid can have long-lasting effects on your body. Do not miss any follow-up visits to your doctor for blood or urine tests.
Store this medication at cool room temperature, away from heat and moisture.
Additional Amicar Information
Amicar - User Reviews
Amicar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.